Anthony Turel, MD - Role of the Opioid System in Immune-Mediated Disease (2017 Conference) (LDN, low dose naltrexone)
The purpose of this presentation is to provide a scientific explanation regarding the various receptors in the opioids system and their potential role in modulating the effects of immune disorders. The biological effects of the opioid receptor antagonist naltrexone is explained and its unique properties are discussed.
Dr Turel offers retrospective studies on the use of low dose naltrexone (LDN) to patients with certain criteria.
Dr Turel concludes that low dose naltrexone (LDN) is well tolerated, modulates the effects of immune disorders and therefore helps patients go into a remission state.
Dr Turel also discusses how high doses of naltrexone could increase risk of stimulating other disease processes.
For more presentations please visit https://ldnresearchtrust.org/ldn-conferences